… options that are being developed for the current COVID-19 … immunotherapies are being
deployed to tackle COVID-19, … immunotherapies could have in severe cases of COVID-19, and …

… of COVID-19 with specific emphasis on cell-based immunotherapeutic approaches. … with
MSCs as an ideal treatment option in combination with other immune-modulator strategies. …

… as the impact on the selection of immunotherapy strategies are discussed in our review. …
that tocilizumab could be a safe option for patients with severe COVID-19 (146) . Subsequently, …

… immunotherapies and those with disabilities as possible high-risk groups for COVID-19 [3]. …
-β compared with other DMTs makes it a suitable option for patients with mild MS during the …

… disease 2019 (COVID-19) the worst pandemic facing this … strategy to help combat COVID-19.
Cancer patients are at the … as COVID-19 in hopes of better-customized treatment options …

… agent of coronavirus disease 2019 (COVID-19), is the most widely spread coronavirus-related …
In addition, we summarize ongoing clinical trials for COVID-19 patients that target …

… ongoing pandemic of coronavirus disease-2019 (COVID-19), … In the initial phase of the
pandemic, this was the only option … was a major drawback that limited its use against COVID-19. …

… , China's NHC has recommended iv XBJ as one of the treatment options in COVID-19 …
of COVID-19 patients. Therefore, it could be a potential target for immunotherapy of COVID-19. …

… in COVID-19 patients at high risk for severe disease. In this article, we present an overview
of the cytokine storm and its implications in COVID-19 … as therapeutic options for COVID-19 …

… as early treatment options to treat outpatients with mild-to-moderate COVID-19 (ref. ). With …
convalescent plasma from COVID-19 survivors might provide passive immunotherapy 40,41 . …